Literature DB >> 15294268

Depletion of atrial natriuretic peptide during longstanding atrial fibrillation.

Maarten P van den Berg1, Isabelle C van Gelder, Dirk J van Veldhuisen.   

Abstract

This review focuses on the relation between atrial fibrillation (AF) and atrial natriuretic peptide (ANP). ANP is produced by the atria secondary to atrial stretch. By causing atrial stretch, acute AF leads to an increase in plasma ANP concentration, which serves to normalize haemodynamics through natriuresis and vasodilation. However, data have been reported suggesting that prolonged AF, by inflicting structural atrial damage, is associated with a reduced capacity by the atria to produce ANP. An inverse relation was thus demonstrated between the duration of AF and plasma ANP concentration. In addition, a reduced ANP response to exercise has been shown to be predictive of unsuccessful cardioversion of AF to sinus rhythm. Finally, ANP has also been shown to predict outcome after a maze operation. Outcome was poor when preoperative plasma ANP concentration was low. Moreover, a high atrial collagen content, as a measure of atrial degeneration, correlated with low ANP. These data indicate that ANP may serve as a marker of atrial integrity, which may help in selecting AF patients for therapeutic interventions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15294268     DOI: 10.1016/j.eupc.2004.04.006

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  7 in total

1.  Level Of Natriuretic Peptide Determines Outcome In Atrial Fibrillation.

Authors:  Qi-Xian Zeng; Ming-Fen Wei; Wei Zhang; Yun Zhang; Jing-Quan Zhong
Journal:  J Atr Fibrillation       Date:  2010-01-01

2.  Biomarkers in the clinical management of patients with atrial fibrillation and heart failure.

Authors:  Ioanna Koniari; Eleni Artopoulou; Dimitrios Velissaris; Mark Ainslie; Virginia Mplani; Georgia Karavasili; Nicholas Kounis; Grigorios Tsigkas
Journal:  J Geriatr Cardiol       Date:  2021-11-28       Impact factor: 3.327

3.  Mechanistic implication of decreased plasma atrial natriuretic peptide level for transient rise in the atrial capture threshold early after ICD or CRT-D implantation.

Authors:  Kojiro Ogawa; Kentaro Yoshida; Yoshiko Uehara; Mari Ebine; Akira Kimata; Hidetaka Nishina; Noriyuki Takeyasu; Yuichi Noguchi; Masaki Ieda; Kazutaka Aonuma; Akihiko Nogami
Journal:  J Interv Card Electrophysiol       Date:  2018-07-17       Impact factor: 1.900

4.  Natriuretic Peptides as Predictors of Atrial Fibrillation Recurrences Following Electrical Cardioversion.

Authors:  Theodoros A Zografos; Demosthenes G Katritsis
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-11-29

Review 5.  Clinical Applications of Natriuretic Peptides in Heart Failure and Atrial Fibrillation.

Authors:  Masako Baba; Kentaro Yoshida; Masaki Ieda
Journal:  Int J Mol Sci       Date:  2019-06-10       Impact factor: 5.923

6.  Sacubitril/Valsartan Improves Left Atrial and Left Atrial Appendage Function in Patients With Atrial Fibrillation and in Pressure Overload-Induced Mice.

Authors:  Ya Suo; Meng Yuan; Hongmin Li; Yue Zhang; Ying Li; Huaying Fu; Fei Han; Changhui Ma; Yuanyuan Wang; Qiankun Bao; Guangping Li
Journal:  Front Pharmacol       Date:  2019-10-29       Impact factor: 5.810

7.  Relationship between duration of heart failure, patient characteristics, outcomes, and effect of therapy in PARADIGM-HF.

Authors:  Su E Yeoh; Pooja Dewan; Akshay S Desai; Scott D Solomon; Jean L Rouleau; Marty Lefkowitz; Adel Rizkala; Karl Swedberg; Michael R Zile; Pardeep S Jhund; Milton Packer; John J V McMurray
Journal:  ESC Heart Fail       Date:  2020-10-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.